{
    "prompt": "Please provide each treatment as a json format with the following JSON schema.\n    {\n        \"Treatment 1\": {\n            \"Disease Name\": ,\n            \"Disease Phase or Condition\": ,\n            \"Drug Name\": ,\n            \"Prior Treatment or Resistance Status\": ,\n            \"Genomic Features\":\n            \"Link to FDA-approved Label\": \n            }\n    }\n    Query: \n    The following is a summarized molecular profile from MSK-IMPACT.\n    Based on this profile, answer with the appropriate treatments for this patient in the format above.\n    Patient ID: P-0071940\nAge: 71\nGender: Male\nSample ID: P-0071940-T01-IM7\nGene Panel: IMPACT505\nCancer Type: Pancreatic Adenocarcinoma\nSample Type: Primary\nTumor Purity: 10.0%\n=============\nDNA Variants:\nKRAS c.33_35delinsCGT (p.G12V) - in 4.00% of 350 reads\nTP53 c.577C>A (p.H193N) - in 3.00% of 755 reads\nCNA Data:\nNo CNA data found.\nStructural Variants:\nNo structural variant data found.\n    ",
    "response": "{\n  \"Treatment 1\": {\n    \"Disease Name\": \"Pancreatic Adenocarcinoma\",\n    \"Disease Phase or Condition\": \"Unresectable or metastatic\",\n    \"Drug Name\": \"Pembrolizumab\",\n    \"Prior Treatment or Resistance Status\": \"Progressed following prior treatment\",\n    \"Genomic Features\": \"High mutational burden (TMB-H) or MSI-high status not specified\",\n    \"Link to FDA-approved Label\": \"https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/125514s148lbl.pdf\"\n  }\n}"
}